Skip to main content
logo
Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
10.83
+0.02 (0.20%)
Oct 9, 2025, 2:46 PM EDT

Astellas Pharma Revenue

Astellas Pharma had revenue of 505.79B JPY in the quarter ending June 30, 2025, with 6.91% growth. This brings the company's revenue in the last twelve months to 1.94T, up 14.29% year-over-year. In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.

Revenue (ttm)
1,944.99B JPY
Revenue Growth
+14.29%
P/S Ratio
1.45
Revenue / Employee
142.56M JPY
Employees
13,643
Market Cap
19.50B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elite Pharmaceuticals105.45M
Glass House Brands221.55M
Veradigm588.02M
Northwest Biotherapeutics1.09M
American Oncology Network1.76B
Silence Therapeutics27.17M
Jushi Holdings256.36M
Nuo Therapeutics1.95M
Revenue Rankings

Astellas Pharma News

More News